Two follicle-stimulating hormone receptor polymorphisms and polycystic ovary syndrome risk: a meta-analysis.

[1]  H. Teede,et al.  Polycystic ovary syndrome , 2016, Nature Reviews Disease Primers.

[2]  Shan Li,et al.  The Asn680Ser polymorphism of the follicle stimulating hormone receptor gene and ovarian cancer risk: a meta-analysis , 2014, Journal of Assisted Reproduction and Genetics.

[3]  W. Almawi,et al.  Polymorphisms of transcription factor-7-like 2 (TCF7L2) gene in Tunisian women with polycystic ovary syndrome (PCOS). , 2014, Gene.

[4]  X. Bi,et al.  Association between FSHR polymorphisms and polycystic ovary syndrome among Chinese women in north China , 2014, Journal of Assisted Reproduction and Genetics.

[5]  Jie-jin Yang,et al.  The association of Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 gene with the metabolic characteristics in Chinese women with polycystic ovary syndrome. , 2013, International journal of clinical and experimental pathology.

[6]  S. Rice,et al.  Metformin Inhibits Follicle-Stimulating Hormone (FSH) Action in Human Granulosa Cells: Relevance to Polycystic Ovary Syndrome , 2013, The Journal of clinical endocrinology and metabolism.

[7]  A. Warth,et al.  Follicle‐stimulating hormone receptor expression in soft tissue sarcomas , 2013, Histopathology.

[8]  Qiupeng Zheng,et al.  Association study between FSHR Ala307Thr and Ser680Asn variants and polycystic ovary syndrome (PCOS) in Northern Chinese Han women , 2013, Journal of Assisted Reproduction and Genetics.

[9]  K. Baek,et al.  Association between INS-VNTR polymorphism and polycystic ovary syndrome in a Korean population , 2012, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[10]  W. Newman,et al.  PCOS and peripheral AMH levels in relation to FSH receptor gene single nucleotide polymorphisms , 2012, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[11]  G. Restagno,et al.  FSH-receptor Ala307Thr polymorphism is associated to polycystic ovary syndrome and to a higher responsiveness to exogenous FSH in Italian women , 2011, Journal of Assisted Reproduction and Genetics.

[12]  M. Duda,et al.  The expression of FSH receptor (FSHR) in the neonatal porcine ovary and its regulation by flutamide. , 2011, Reproduction in domestic animals = Zuchthygiene.

[13]  Lin He,et al.  Two FSHR variants, haplotypes and meta-analysis in Chinese women with premature ovarian failure and polycystic ovary syndrome. , 2010, Molecular genetics and metabolism.

[14]  K. Baek,et al.  Genetic variations of follicle stimulating hormone receptor are associated with polycystic ovary syndrome. , 2010, International journal of molecular medicine.

[15]  N. Georgopoulos,et al.  Serum AMH, FSH, and LH levels in PCOS. , 2010, Fertility and sterility.

[16]  M. Namiki,et al.  Single nucleotide polymorphism analysis of the follicle-stimulating hormone (FSH) receptor in Japanese with male infertility: identification of codon combination with heterozygous variations of the two discrete FSH receptor gene. , 2009, Endocrine journal.

[17]  A. Hofman,et al.  Genetic polymorphisms of GnRH and gonadotrophic hormone receptors affect the phenotype of polycystic ovary syndrome. , 2009, Human reproduction.

[18]  A. Bideci,et al.  Genetic polymorphisms of FSHR, CYP17, CYP1A1, CAPN10, INSR, SERPINE1 genes in adolescent girls with polycystic ovary syndrome , 2009, Journal of Assisted Reproduction and Genetics.

[19]  M. Massobrio,et al.  Mutations and Polymorphisms of the FSH Receptor (FSHR) Gene: Clinical Implications in Female Fecundity and Molecular Biology of FSHR Protein and Gene , 2008, Obstetrical & gynecological survey.

[20]  L. Salmaso,et al.  Analysis of single nucleotide polymorphisms of FSH receptor gene suggests association with testicular cancer susceptibility. , 2008, Endocrine-related cancer.

[21]  C. Bose.  Follicle stimulating hormone receptor in ovarian surface epithelium and epithelial ovarian cancer. , 2008, Oncology research.

[22]  M. Simoni,et al.  Polymorphism of the FSH receptor and ovarian response to FSH. , 2007, Annales d'endocrinologie.

[23]  Raghu Kacker,et al.  Random-effects model for meta-analysis of clinical trials: an update. , 2007, Contemporary clinical trials.

[24]  L. Kiesel,et al.  A common single nucleotide polymorphism in exon 10 of the human follicle stimulating hormone receptor is a major determinant of length and hormonal dynamics of the menstrual cycle. , 2005, The Journal of clinical endocrinology and metabolism.

[25]  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. , 2004, Fertility and sterility.

[26]  B. Fauser,et al.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). , 2004, Human reproduction.

[27]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[28]  S. Ng,et al.  Absence of Mutations in the Coding Regions of Follicle-Stimulating Hormone Receptor Gene in Singapore Chinese Women with Premature Ovarian Failure and Polycystic Ovary Syndrome , 2001, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[29]  G. Conway,et al.  Mutation screening and isoform prevalence of the follicle stimulating hormone receptor gene in women with premature ovarian failure, resistant ovary syndrome and polycystic ovary syndrome , 1999, Clinical endocrinology.

[30]  A. Dunaif.  Polycystic ovary syndrome: Preface , 1999 .

[31]  E. Nieschlag,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Mutational Analysis of the Follicle-Stimulating Hormone (FSH) Receptor in Normal and Infertile Men: Identification and Characterization of Two Dis , 2022 .

[32]  W. Haenszel,et al.  Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.